TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Microbiological proven late onset sepsis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Food Safety Kitchen Audit Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional Adequacy Ratio (NAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of diagnostic test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of diagnostic test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of the novel point-of-care diagnostic test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug and/or metabolite concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disease recurrence reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Resting State BOLD Signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of grade 4, non-hematologic dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: number of participants with positive fungal growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Event free situation during follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Heart Rate Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastolic and Systolic Blood Pressure Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participant With Adverse Event (AE) and Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Numerical Rating Scale (NRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oswestry Low Back Pain Disability Questionnaire (OLDPDQ) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tolerance on ocular surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With CKD Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Optimal Blood Pressure Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Patients With Optimal Glucose Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthy relationship measure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Job readiness measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Financial assistance measure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Life Satisfaction measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Number of Incontinence Episodes Per 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients with bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients with hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients in whom a loss of airway has occurred
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients with atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients with hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with barotrauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in anxious symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants With > 20 Percent Decline in Calculated Panel Reactive Antibody (cPRA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Received Successful Kidney Transplantation Within 12 Months
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Patients With Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients alive at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: success rate of total mastectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients presenting diagnosis of small fiber neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: All seizures following the primary doses of PEDIARIX and DTaP vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Medically-attended fever following the first dose of PEDIARIX and DTaP vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life Scores related to swallowing
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Scores related to speech
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to pass flatus after elective caesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Uptake detected by investigational imaging agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED95 of remifentanil bolus in mcg/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevention of pegfilgrastim-induced back and leg pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of death from any cause, stroke, transient ischemic attack, myocardial infarction, unplanned hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Perfused blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: success rate of resuscitation
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coronary calcium quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in WOMAC Pain Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ultrasound Image Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Savings obtained by avoided admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients achieving drug concentration >= 1.0 uM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Dose limit toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Biological effective dose (BED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deep sternal wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in VO2 (maximal oxygen uptake in ml/(kg*min))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in walking distance (in meters) in 6 minute walk test (MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in periprosthetic bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Plasma Concentration Time Curves (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Chronic Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of stroke patients receiving thrombolysis treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tourniquet application retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Any Grade or High Grade (Gleason Score 7 or Higher) Prostate Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Interview-rated posttraumatic stress at 3 months follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Interview-rated posttraumatic stress at 6 months follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antibody levels after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in Plaque Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Analytical performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infectious Morbidity Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with unacceptable toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Median percent change in Treg levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Length of stay (LOS) in hospital after surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Peak Force of Pain Tolerance Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of Ridaforolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy (Clinical Benefit Rate [CBR]) of Ridaforolimus in Advanced Sarcoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in problem solving skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in anxiety and depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in child physical and emotional functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Relief from breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Low pulse oximetry incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the Nocturnal Leg Cramp Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate after 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in lower limb extensor power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: periodontal outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulatory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum monoclonal immunoglobulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bone marrow histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Number of Retreatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Change From Baseline in Study Eye Best-corrected VA Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced school absences
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of Patients With Undetectable PSA Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in BMI Percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in severity of morning stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Gut microbiome composition of exposed group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Impact of Event Scale-Revised (IES-R) of exposed group
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in signs and symptoms of lupus activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Control Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung Function-FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to Daily Controller Inhaler
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Kidney graft outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prostaglandin E2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF-Alpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Major Complications Free Survival Probability
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with locoregional tumor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cardiovascular disease risk factor knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: WOMAC pain (WP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in ADAS-Cog13 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood pressure variability (BPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure (systolic, diastolic, mean arterial)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in adult pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cold cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in hot cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Disease Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neuromuscular Recovery Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence to physical exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Successful completion of key contact interviews and focus groups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Donor T cell chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neurobehavioral Symptom Inventory (NSI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Gastro-intestinal tolerance: vomiting or diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Refeeding syndrome; hypokalemia and hypophosphatemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of cervical ripening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: H reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hair length in group A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness of oral combination chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total days of NCPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Technical success of CO2 cholangiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in the Clinical Attachment Level Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dead patients
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients requiring prolonged intensive care unit stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Clinically Relevant Abnormalities for Clinical Laboratory Evaluation, Vital Signs, and ECG Recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Total PANSS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarker level linked with detection of metastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Return to sport
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Re-injuries in the same ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of complete pathologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported Hunger
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Yield of ocular POCUS in diagnosing optic disc swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemodynamic data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiratory data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adverse events after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of therapy for the index treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time between subsequent treatment lines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sequencing of treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual Assessment of Breast Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Semiquantitative Assessment of Breast Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in cognitive function (objective measurement)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in cognitive function (subjective measurement)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants receiving new therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: delay discounting
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post-op morphine usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Abdominal Pain scores postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need of pain medication postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Postoperative Residual Neuromuscular Blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in brain reward system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Metabolism in AN patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Baseline body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm birth before 37 weeks of gestation
Endpoint domain: Mortality/survival
Primary endpoint: Decrease in number of monthly Heavy Drinking Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of omalizumab
Endpoint domain: Adverse events/effects
Primary endpoint: Occlusion and lysis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast and Cmax of dutasteride and tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Solicited Local Adverse Events after First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Solicited Local Adverse Events after Second Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Solicited Systemic Adverse Events after First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Solicited Systemic Adverse Events after Second Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Unsolicited Adverse Events after First Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Length of stay for ED admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Biomarkers predictive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collection and assessment of expected and unexpected adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Quantification of [18F]DPA-714 binding in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perioperative Bleeding Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of suicide attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Depth of the injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes